Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration

Anti-Cancer Drugs

Volumn 7, Issue 5, 1996, Pages 596-603

  Jacquet, Pierrre ^a   Stuart, O Anthony ^a   Chang, David ^b   Sugarbaker, Paul H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

^b WESTAT   (United States)

Author keywords

doxorubicin; intra abdominal pressure; intraperitoneal chemotherapy; pharmacokinetics

Indexed keywords

DOXORUBICIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROSTATIC PRESSURE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PERITONEAL FLUID; PRIORITY JOURNAL; RAT;

EID: 0029837953     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199607000-00016     Document Type: Article

References (26)

1. Cunliff WJ, Sugarbaker PH. Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg 1989; 76: 1082-90.
2. Markman M. Intraperitoneal chemotherapy for malignant diseases of the gastrointestinal tract. Surg Gynecol Obstet 1987; 164: 89-93.
3. Sugarbaker PH. Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis. Dis Colon Rectum 1994; 37: S115-22.
4. Dedrick RL. Theoretical and experimental bases of intraperitoneal chemotherapy. Semin Oncol 1985; 12: 1-6.
5. Jacquet P. The peritoneal-plasma barrier. Cancer Treat Res 1996; 82: 53-63.
6. Jacquet P, Vidal-Jove J, Zhu B, Sugarbaker PH. Peritoneal carcinomatosis from gastrointestinal malignancy: natural history and new prospects for management. Acta Chir Belg 1994; 94: 191-7.
7. Sugarbaker PH, Stuart OA, Vida-Jove J, Pewssagno A, DeBruijn EA. Studies of the peritoneal plasma barrier after systemic mitomycin C administration. Reg Cancer Treat 1993; 4: 188-94.
8. Flessner MF, Dedrick RL, Schultz JS. A distributed model of peritoneal-plasma transport: theoretical considerations. Am J Physiol 1984; 246: R597-607.
9. Sugarbaker PH, Graves T, de Bruijn EA, Cunliffe WJ. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res 1990; 50: 5790-4.
10. Kerr DJ, Kaye SB. Aspects of cytotoxic drug penetration with particular reference to anthracyclines. Cancer Chem Pharmacol 1987; 19: 1-5.
11. Los G, McVie JG. Experimental and clinical status of intraperitoneal chemotherapy. Eur J Cancer 1990; 26: 755-62.
12. McVie JG, Dikhoff TG, van der Heide J. Tissue concentration of platinum after intraperitoneal cisplatin administration in patients. Proc Am Ass Cancer Res 1985; 26: 162.
13. Myers CE, Collins JM. Pharmacology of intraperitoneal chemotherapy. Cancer Invest 1983; 1: 395-407.
14. Israel M, Pegg WJ, Wilkinson PM, Garnick MB. Liquid chromatography analysis of adriamycin and metabolites in biological fluids. J Liq Chromatograph 1978; 1: 795-809.
15. Mario L, Jusko WJ. LAGRAM program for area and moments in pharmacokinetics analysis. Comp Prog Biomed 1983; 203-16.
16. Jain RK. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst 1989; 81: 570-6.
17. Curti BD. Physical barriers to drug delivery. Crit Rev Oncol Hematol 1993; 14: 29-39.
18. Hori K, Suzuki M, Abe I, Saito S. Increased tumor tissue pressure in association with the growth of rat tumors. Jpn J Cancer Res 1986; 77: 65-73.
19. Leunig M, Goetz AE, Dellian M, Zetterer G, Gamarra F, Jain RK, Messmer K. Interstitial fluid pressure in solid tumors following hyperthermia: possible correlation with therapeutic response. Cancer Res 1992; 52: 487-90.
20. Lee I, Boucherr Y, Jain RK. Nicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implications. Cancer Res 1992; 52: 3237-40.
21. Ozols RF, Young RC, Speyer JL, et al. Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer. Cancer Res 1982; 42: 4265-9.
22. Chang BK. Tissue distribution of adriamycin administered intraperitoneally vs. intravenously, with special emphasis on the pancreas. Bull Cancer 1982; 69: 172-5.
23. Kelly DE, Wood RL, Enders AC. The muscles. In: Kelly DE, Wood RL, Ender AC, eds. Bailey's textbook of microscopic anatomy. Baltimore, MD: Waverly Press 1984.
24. Benet LZ. Pharmacokinetics: absorption, distribution and elimination. In: Katzung BC, ed. Basic and clinical pharmacology. Norwalk, CT: Appleton & Lange 1992; 10-35.
25. Karran S. Progress in the assessment of liver blood flow in health and disease. J R Coll Surg Edinb 1990; 35: 207-17.
26. Schein M, Wittman DH, Aprahamian CC, Condon RE. The abdominal compartment syndrom: the physiologic and clinical consequences of elevated intra-abdominal pressure. J Am Coll Surg 1995; 180: 745-53.